11β-hydroxylase deficiency screening

Congenital adrenal hyperplasia main page
11β-hydroxylase deficiency Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 11β-hydroxylase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
11β-hydroxylase deficiency screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of 11β-hydroxylase deficiency screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on 11β-hydroxylase deficiency screening
CDC on 11β-hydroxylase deficiency screening
11β-hydroxylase deficiency screening in the news
Blogs on 11β-hydroxylase deficiency screening
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Risk calculators and risk factors for 11β-hydroxylase deficiency screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

There is insufficient evidence to recommend routine screening for 11β-hydroxylase deficiency.

Screening

There is insufficient evidence to recommend routine screening for 11β-hydroxylase deficiency.